Wright & McGurk to Consumers: FDA Advisory Panel Classifies Transvaginal Mesh as High Risk

Wright & McGurk is warning consumers of a recent FDA advisory panel recommendation to reclassify transvaginal mesh as a high risk device. (PRWEB) October 05, 2012 Wright & McGurk is warning consumers that transvaginal mesh continues to face scrutiny. Based upon the high number of complaints and alleged life altering consequences, an advisory panel to the FDA has looked deeper into the transvaginal mesh device. This advisory panel has recently recommended that transvaginal mesh be reclassified as a high risk device. This reclassification would force manufacturers to conduct rigorou
Contributor
PR Web
PR Web
Lanham, Maryland
Law Marketing
1.800.345.5572
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations
Download

Related Documents in PR Web
MCLE Sales

Categories